Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00677612
Recruitment Status : Terminated (Lack of financial support)
First Posted : May 14, 2008
Last Update Posted : December 29, 2009
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Tokyo University